Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for hand function recovery after stroke
NCT01422161Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2010
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in stroke, sponsored by NYU Langone Health. Started Apr 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
stroke
Beyond the preview
Go deeper on NCT01422161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422161.